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HIV-­‐1	  proteins	  form	  numerous	  complex	  
interacDons	  with	  human	  proteins	  over	  the	  course	  
of	  an	  HIV-­‐1	  infecDon1.	  	  
The	  purpose	  of	  this	  study	  has	  been	  to	  develop	  a	  
tool	  to	  aid	  in	  elaboraDng	  on	  the	  group	  of	  the	  
protein	  interacDons	  surrounding	  the	  HIV	  protein	  
Vif	  that	  have	  been	  described	  previously.	  
	  	  
Vif	  is	  an	  HIV	  protein	  that	  funcDons	  to	  
disarm	  the	  innate	  immune	  response	  
against	  HIV	  by	  restricDng	  a	  group	  of	  
proteins	  known	  as	  the	  APOBEC3	  
enzymes2.	  These	  enzymes	  catalyze	  
the	  conversion	  of	  cytosines	  to	  uracils	  
in	  cDNA	  synthesized	  during	  retroviral	  
replicaDon,	  thus	  lowering	  the	  
infecDvity	  of	  the	  retroviruses3.	  
	  
Previous	  studies	  that	  have	  idenDﬁed	  
the	  human	  proteins	  interacDng	  with	  
Vif	  have	  used	  mass-­‐spectrometry	  
analysis	  of	  immunoprecipitated	  Vif	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Mass	  spectrometry	  	  
analysis	  
293T	  Jurkat	  
complexes	  amer	  having	  
overexpressed	  Vif	  in	  	  
immortalized	  and	  transformed	  
human	  cell	  lines,	  such	  as	  293T	  
and	  Jurkat4,5.	  
	  
Although	  these	  studies	  have	  
pointed	  out	  several	  crucial	  
interacDons,	  I	  hypothesize	  that	  
there	  are	  novel	  protein	  
interacDons	  with	  Vif	  during	  a	  
true	  HIV-­‐1	  infecDon	  in	  H9	  or	  in	  
Primary	  CD4+	  T	  cells.	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The	  nef	  reading	  frame	  of	  the	  virus	  was	  used	  to	  encode	  the	  epitope	  
tagged	  Vif	  protein.	  The	  wildtype	  vif	  sequence	  overlaps	  with	  pol	  at	  
the	  5’	  end	  and	  vpr	  at	  the	  3’	  end,	  so	  aUaching	  an	  epitope	  tag	  to	  the	  
end	  of	  the	  wildtype	  protein	  would	  have	  been	  challenging.	  Previous	  
studies	  have	  also	  shown	  that	  the	  Nef	  protein	  is	  dispensible	  in	  most	  
cell	  cultures.	  Two	  constructs	  encoding	  either	  an	  epitope	  tagged	  vif	  
or	  GFP	  in	  the	  nef	  reading	  frame	  were	  produced	  as	  well	  as	  two	  
analogous	  constructs	  with	  two	  premature	  stop	  codons	  in	  the	  
wildtype	  vif	  sequence.	  The	  epitope	  tag	  chosen	  was	  the	  HA	  tag.	  	  	  	  
The	  viral	  constructs	  above	  were	  transfected	  into	  293T	  cells	  and	  
their	  infecDvity	  was	  measured	  through	  the	  CEM	  GFP	  reporter	  cell	  
line.	  Protein	  levels	  of	  the	  cells	  were	  also	  measure	  via	  western	  blot.	  
The	  infecDvity	  assays	  of	  the	  viral	  constructs	  are	  promising	  
because	  they	  show	  similar	  levels	  of	  infecDvity	  for	  cells	  
transfected	  with	  a	  plasmid	  encoding	  APOBEC3G	  and	  a	  vector	  
control.	  This	  indicates	  that	  the	  epitope	  tagged	  Vif	  protein	  is	  
sDll	  fully	  capable	  of	  degrading	  APOBEC3G.	  	  
	  
The	  western	  blots	  of	  the	  viral	  parDcles	  show	  precisely	  what	  
was	  expected	  in	  that	  there	  are	  low	  levels	  of	  APOBEC3G	  being	  
packaged	  into	  both	  the	  viral	  constructs	  and	  the	  wildtype	  GFP	  
virus.	  This	  is	  consistent	  with	  infecDvity	  levels	  observed	  
previously.	  	  
	  
The	  tests	  performed	  on	  the	  viral	  constructs	  seem	  to	  indicate	  
that	  they	  are	  funcDonal	  viruses.	  These	  tools	  will	  be	  signiﬁcant	  
in	  developing	  a	  more	  representaDve	  model	  of	  protein	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